WEKO3
アイテム
Efficacy of Tadalafil Add-on Treatment for Men with Lower Urinary Tract Symptoms Refractory to Alpha-1 Adrenoceptor Blockers
https://dmu.repo.nii.ac.jp/records/1473
https://dmu.repo.nii.ac.jp/records/14736217d9c3-6d23-43c6-9def-090e9c724f1d
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
DJMS-44-1-Yagi2-本文 (86.1 kB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| タイトル | ||||||
| タイトル | Efficacy of Tadalafil Add-on Treatment for Men with Lower Urinary Tract Symptoms Refractory to Alpha-1 Adrenoceptor Blockers | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | tadalafil | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | benign prostatic hyperplasia | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | lower urinary tract symptoms | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | refractory to alpha-1 adrenoceptor blockers | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| 著者 |
Yagi, Hiroshi
× Yagi, Hiroshi× Arai, Gaku× Soh, Shigehiro× Okada, Hiroshi |
|||||
| 著者所属 | ||||||
| 値 | Department of Urology, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan | |||||
| 著者所属 | ||||||
| 値 | Department of Urology, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan | |||||
| 著者所属 | ||||||
| 値 | Department of Urology, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan | |||||
| 著者所属 | ||||||
| 値 | Department of Urology, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan | |||||
| 書誌情報 |
Dokkyo Journal of Medical Sciences 巻 44, 号 1, p. 17-23, 発行日 2017-03-25 |
|||||
| 要旨 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | Introduction：To evaluate the efficacy and safety of once daily phosphodiesterase type 5 inhibitor(PDE5i) tadalafil as an add-on treatment for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia（BPH/LUTS）refractory to an alpha 1-blocker（a1-blocker）. Materials and Methods：This study enrolled men aged ＞50 years with BPH/LUTS and erectile dysfunction(ED) that were refractory to ＞3 months of a1-blocker. We defined “refractory” as an international prostate symptoms score (IPSS) of ＞8 and a maximum flow rate (Qmax) ＜15 despite in no space take of an a1-blocker. Patients with contraindications to phosphodiesterase-5 inhibitors；those with symptoms of other diseases that were difficult to differentiate from BPH/LUTS；and those with postvoid residual of ＞100 ml were excluded. Eligible patients received added-on treatment with tadalafil 5 mg/day for 12 weeks. Results：Tadalafil add-on treatment significantly improved the IPSS parameters in terms of total score（P＜0.001）, subscore for storage（P＝0.001）, subscore for voiding（P＜0.001）, and quality of life（P＝0.002）. The 3-day frequency volume chart showed significant improvements in mean number of daily nocturnal micturations（P＝0.002）, nocturnal polyuria index（P＝0.001）, and hours of undisturbed sleep（P＝0.006）. Five patients dropped out because of an adverse event：two with a headache, two with dizziness and one with dyspepsia. There were no serious adverse events. Conclusion：Tadalafil add-on treatment was effective for patients with BPH/LUTS and ED that were resistant to a1-blockers. |
|||||
| 記事種別 | ||||||
| 値 | Original | |||||
| 出版者 | ||||||
| 出版者 | 獨協医学会 | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 03855023 | |||||
| 書誌レコードID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AA00629581 | |||||
| 表示順 | ||||||
| 値 | ４ | |||||
